Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT04513444

Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy

Led by Institut Claudius Regaud · Updated on 2026-04-20

45

Participants Needed

1

Research Sites

346 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This phase II, randomized, non-comparative and monocentric study aims to evaluate the interest of medical hypnosis in the management of anxiety in patients who are moderately anxious, anxious or very anxious during their radiotherapy treatment. 45 patients will be randomized into the following arms: * Arm A (standard): relaxation with music listening during radiotherapy treatment * Arm B (experimental): relaxation with music listening and hypnosis during radiotherapy treatment For the study each patient will be followed during 2 months.

CONDITIONS

Official Title

Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at enrollment
  • Diagnosis of localized or metastatic solid malignant tumor
  • Receiving radiotherapy treatment for the first time in the follow-up at IUCT-O
  • Radiotherapy treatment includes at least 15 sessions
  • Moderate to very anxious status with STAI-Y score of 46 or higher at inclusion
  • Eastern Cooperative Oncology Group (ECOG) performance status 2 or less
  • Signed informed consent before study procedures
  • Affiliated with French Social Health Insurance
Not Eligible

You will not qualify if you...

  • Does not understand the French language
  • Psychiatric disorders requiring antidepressant or antipsychotic treatment
  • Hearing problems
  • Pregnant or breastfeeding women
  • Psychological, family, geographical or sociological conditions preventing study compliance
  • Under legal protection or has lost freedom by administrative or legal decision

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France, 31059

Actively Recruiting

Loading map...

Research Team

A

Anne DUCASSOU

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here